Biotech Values

[ghmm]

ARIA:

The merger documents are out. The initial offer was for $20 a share. A second offer for $22 and they were told if its in the mid 20's would recommend it to board. At the time 3 other companies were contacted. 2 had non-disclosures. One came back with questions for management but by that time had agreed to recommend Takeda deal to board. Begins on page 21 for those interested (I usually like reading these to see how things transpire but this is one of the less interesting I've read)

https://www.sec.gov/Archives/edgar/data/884731/000119312517013286/d281553dsc14d9.htm